ADC Therapeutics SA
(ADCT)
undefined
undefined%
At close: undefined
1.88
0.53%
After-hours Dec 13, 2024, 07:50 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -240.05M | -155.80M | -230.03M | -246.29M | -116.48M | -123.10M | -89.86M |
| Depreciation & Amortization | 3.27M | 2.33M | 2.63M | 2.19M | 1.65M | 740.00K | 341.00K |
| Stock-Based Compensation | 13.49M | 49.32M | 60.48M | 37.59M | 1.12M | 469.00K | 980.00K |
| Other Working Capital | -8.30M | 18.40M | 6.16M | 10.44M | -2.34M | -1.14M | -1.80M |
| Other Non-Cash Items | 23.23M | 1.07M | -24.70M | 25.10M | -1.19M | -891.00K | 36.00K |
| Deferred Income Tax | 37.10M | -708.00K | -21.48M | 327.00K | 1.21M | 935.00K | 48.00K |
| Change in Working Capital | 44.27M | -33.01M | -20.28M | 12.36M | -7.88M | 481.00K | 13.51M |
| Operating Cash Flow | -118.69M | -136.79M | -233.38M | -168.73M | -121.58M | -121.36M | -74.94M |
| Capital Expenditures | -3.22M | -2.30M | -6.38M | -2.81M | -2.15M | -2.47M | -3.16M |
| Acquisitions | - | - | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - | - | - |
| Other Investing Acitivies | - | -210.00K | -297.00K | -19.00K | -100.00K | -36.00K | -92.00K |
| Investing Cash Flow | -3.22M | -2.51M | -6.67M | -2.83M | -2.25M | -2.51M | -3.25M |
| Debt Repayment | - | -2.71M | 48.61M | 61.75M | -1.00M | - | - |
| Common Stock Repurchased | - | -221.00K | - | - | -141.00K | -24.00K | - |
| Dividend Paid | - | - | - | - | - | - | - |
| Other Financial Acitivies | 73.88M | -4.32M | 218.78M | 54.00K | 101.61M | -24.00K | - |
| Financial Cash Flow | 73.88M | -593.00K | 267.39M | 494.97M | 100.51M | -24.00K | 197.24M |
| Net Cash Flow | -47.84M | -140.10M | 27.35M | 323.64M | -23.26M | -123.94M | 119.08M |
| Free Cash Flow | -121.90M | -139.09M | -239.75M | -171.54M | -123.73M | -123.83M | -78.10M |